Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extracorporeal shock wave therapy vs intraplaque verapamil injection for Peyronie's disease
IRCT20130812014333N169Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of verapamil in Peyronie's disease (2 arms), sponsored by Kermanshah University of Medical Sciences. Started Jun 2021; status: completed.
02
Drugs
verapamil
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on IRCT20130812014333N169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N169.